Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01983202
Other study ID # 25624548
Secondary ID
Status Completed
Phase N/A
First received October 24, 2013
Last updated November 6, 2013
Start date January 2003
Est. completion date September 2013

Study information

Verified date November 2013
Source Odense University Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection Agency
Study type Observational

Clinical Trial Summary

The aim of the study is to investigate body composition in newborn children of women with PCOS and controls and to investigate adverse obstetric outcomes in pregnant women with PCOS.


Description:

A prospective cohort study investigating 208 women with PCOS giving birth after singleton pregnancies at Odense Univesity Hospital during 2003-2011 and a date-of-childbirth matched control group of 1040 women. Anthropometric data from children is recorded as well as data on maternal parity, age, pre-gestational BMI, and adverse obstetric outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 1248
Est. completion date September 2013
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Diagnosed with PCOS and giving birth during 2003-2011

Exclusion Criteria:

- Multiple pregnancy

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
Denmark Department of Endocrinology, Odense University Hospital Odense

Sponsors (1)

Lead Sponsor Collaborator
Odense University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Neonatal complications Registration of Apgar score 5 minutes after birth and admission to neonatal intensive care unit. Date of birth (1 day) No
Primary Anthropometric measures Abdominal circumference, birth weight, birth length, and head circumference. Date of birth (1 day) No
Secondary Adverse obstetric outcomes Presence of gestational diabetes mellitus, pregnancy induced hypertension, or pre-eclampsia during pregnancy. Registration of gestational age at childbirth, medical induction of birth, caesarean section,instrumental delivery, anal sphincter rupture, and shoulder dystocia. From beginning of pregnancy until the date of delivery (approximately 9 months) No